{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:28:08Z","timestamp":1770830888646,"version":"3.50.1"},"reference-count":43,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T00:00:00Z","timestamp":1532995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["KAKENHI 17K15635"],"award-info":[{"award-number":["KAKENHI 17K15635"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Medicine"],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Programmed cell death ligand\u20101 (<jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\u2010L1) is a ligand for programmed cell death\u20101 (<jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\u20101) that negatively regulates T\u2010cell activation and plays a crucial role in suppressing anti\u2010tumor host immunity. Although <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\u2010L1 is a promising immunotherapy target in various cancers, including urothelial carcinoma (<jats:styled-content style=\"fixed-case\">UC<\/jats:styled-content>), the prognostic significance of <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\u2010L1 in <jats:styled-content style=\"fixed-case\">UC<\/jats:styled-content> is unclear. As platelets help protect tumor cells from immune elimination in the circulatory system, we hypothesized that tumor <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\u2010L1 and circulating platelets might synergistically promote tumor metastasis, and that the prognostic significance of <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\u2010L1 might vary according to platelet count. We immunohistochemically examined tumor <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\u2010L1 expression in 271 patients with upper tract <jats:styled-content style=\"fixed-case\">UC<\/jats:styled-content>, which revealed <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\u2010L1 positivity in 31 of 271 cases (11%). The associations of tumor <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\u2010L1 expression with outcomes varied among patients with high or low platelet counts (<jats:italic>P<\/jats:italic><jats:sub>interaction<\/jats:sub>\u00a0&lt;\u00a00.004). Among patients with high platelet counts (N\u00a0=\u00a0136), <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\u2010L1 positivity (N\u00a0=\u00a015) was significantly associated with shorter metastasis\u2010free survival (univariate hazard ratio [<jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>]: 6.23, 95% confidence interval [<jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>]: 2.95\u201013.1; multivariate <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>: 2.68, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 1.27\u20105.64) and shorter overall survival (univariate <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>: 4.92, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 2.14\u201011.3, multivariate <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>: 2.78, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 1.19\u20106.51). In contrast, among patients with low platelet counts (N\u00a0=\u00a0135), <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\u2010L1 positivity (N\u00a0=\u00a016) was not significantly associated with these outcomes. Our results suggest that tumor <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\u2010L1 expression and platelet count might interact and help regulate tumor progression. Although a larger prospective study is needed to validate our findings, this relationship is important to consider, as immunotherapies targeting the <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\u20101\/<jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\u2010L1 axis have gained significant attention as promising therapies for <jats:styled-content style=\"fixed-case\">UC<\/jats:styled-content>.<\/jats:p>","DOI":"10.1002\/cam4.1686","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T08:35:27Z","timestamp":1533026127000},"page":"4330-4338","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The prognostic value of PD\u2010L1 expression in upper tract urothelial carcinoma varies according to platelet count"],"prefix":"10.1002","volume":"7","author":[{"given":"Yu","family":"Miyama","sequence":"first","affiliation":[{"name":"Department of Pathology Graduate School of Medicine The University of Tokyo  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4945-6207","authenticated-orcid":false,"given":"Teppei","family":"Morikawa","sequence":"additional","affiliation":[{"name":"Department of Pathology Graduate School of Medicine The University of Tokyo  Tokyo Japan"},{"name":"Department of Diagnostic Pathology NTT Medical Center Tokyo  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimpei","family":"Miyakawa","sequence":"additional","affiliation":[{"name":"Department of Urology Graduate School of Medicine The University of Tokyo  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Koyama","sequence":"additional","affiliation":[{"name":"Department of Pathology Graduate School of Medicine The University of Tokyo  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taketo","family":"Kawai","sequence":"additional","affiliation":[{"name":"Department of Urology Graduate School of Medicine The University of Tokyo  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruki","family":"Kume","sequence":"additional","affiliation":[{"name":"Department of Urology Graduate School of Medicine The University of Tokyo  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Fukayama","sequence":"additional","affiliation":[{"name":"Department of Pathology Graduate School of Medicine The University of Tokyo  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,7,31]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3239"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1613683"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33297-X"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30065-7"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30501"},{"key":"e_1_2_7_7_1","first-page":"101","article-title":"Upper tract urothelial carcinoma: special considerations","volume":"14","author":"Hutchinson R","year":"2016","journal-title":"Clin Adv Hematol Oncol"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32455-2"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-006-0266-z"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0731"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2013.08.023"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv009"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2014.10.020"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2016.11.011"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.3233\/BLC-160067"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19913"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-017-0941-2"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2017.06.086"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.513"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.26495"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1207756"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.7547"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60209-8"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3004"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.02.028"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-3503-2"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2010.03725.x"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0603"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-016-0545-8"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.9761"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2016.117"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2016.11.2228"},{"key":"e_1_2_7_33_1","first-page":"450","article-title":"Interaction between circulating cancer cells and platelets: clinical implication","volume":"27","author":"Lou XL","year":"2015","journal-title":"Chin J Cancer Res"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29847"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-016-0011"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1134412"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2016.95"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2443"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2017.04.102"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2017.188"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30760"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-015-4781-z"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2017.06.003"},{"key":"e_1_2_7_44_1","first-page":"3225","article-title":"Impact of preoperative thrombocytosis on pathological outcomes and survival in patients treated with radical cystectomy for bladder carcinoma","volume":"34","author":"Moschini M","year":"2014","journal-title":"Anticancer Res"}],"container-title":["Cancer Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcam4.1686","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.1686","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cam4.1686","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/am-pdf\/10.1002%2Fcam4.1686","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.1686","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T09:24:00Z","timestamp":1744190640000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cam4.1686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,31]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["10.1002\/cam4.1686"],"URL":"https:\/\/doi.org\/10.1002\/cam4.1686","archive":["Portico"],"relation":{},"ISSN":["2045-7634","2045-7634"],"issn-type":[{"value":"2045-7634","type":"print"},{"value":"2045-7634","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,31]]},"assertion":[{"value":"2018-04-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}